FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells. - Wikidata - wikimedia - TriplyDB

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

http://www.wikidata.org/entity/Q35273654

about

Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Gastric cancer: The times they are a-changin'Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer FOXM1 is a therapeutic target for high-risk multiple myeloma.HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1 Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells The relationship between platinum drug resistance and epithelial-mesenchymal transition.Increased FoxM1 expression is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.VSV based virotherapy in ovarian cancer: the past, the present and …future?Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

P2860

Q26741846-1032CFDC-1C52-42FD-A672-7889B8DA2826 Q26776195-4518BA84-1C0E-447C-A29A-7FF298AE40E8 Q26785676-7BA5D19E-AD3E-4099-A580-D6EA20E0E68B Q33651605-F053C6EF-E8A5-466D-83FC-4899200F4C64 Q33779379-833B89A5-7A8B-42A2-AE43-237AC0465CF3 Q35976142-99490F35-574A-42B7-AD99-590052F40B02 Q36048518-D3602A72-8FF0-464E-91CB-5EEB900C216D Q36293810-63911124-81E7-451D-8F7C-EE16738FC983 Q36413366-45EF3A4A-EBEA-4E52-8FB3-DE00F0C168FF Q36413849-C7265570-248D-4290-BAF3-43BF5206D955 Q36545318-D0897631-509A-4D68-8738-1C96C209B001 Q36562209-7C27CB0C-0712-4F30-8242-66B2FD9E61FD Q36610848-7DB50449-9349-483A-8D7F-24D123E67D76 Q36651828-B04724F2-4CDD-4718-9EAC-2C040CC676D8 Q36783627-57F33FB8-9F10-421A-9BAD-3CAFCE81FCF6 Q37176592-D7DB240E-9CA7-4C42-8B63-95B21E21F80B Q37257711-E122FDE7-7D06-4C0A-A7D1-6AC0793505DB Q37392807-B43E11E0-62D6-4A5B-9A7C-995B5189DEA9 Q37644850-9D7FFF10-8DCC-4E79-94E5-9A85201AD7B4 Q37723691-E5B71E30-75AC-4CD6-BC3E-BEA402CC53CC Q37741081-DC892354-665D-4739-815E-4E6FFE4A60C4 Q37745486-1BC42CD8-968D-4B77-A37E-F8B5BB3837BF Q37747417-1C043E96-7C9F-453D-B575-909B1CAC9C11 Q38715514-FC8397C5-F1D6-4D44-B55E-B88E8CF8B813 Q38800311-08EEB390-EE63-4606-BB74-9AF2411A28EE Q38814178-9A07EDF0-3C44-4C9E-8053-A3F533B6D446 Q38862527-2AB7AF14-D5C8-4AB4-B9EB-70298B7076B8 Q39061847-A0C86F7D-39AA-41C6-A363-EFD2B264C7AA Q39077208-6F2D43C3-BAEC-4C67-9ACA-7FA4C2D7AD61 Q39411041-3D30B156-7251-4483-8667-837210695E38 Q39991261-32FB5833-5E85-45D6-8B06-3CE7DDCC5F7D Q41441101-004F1DA5-E965-4161-A323-C648F40EFF57 Q41552639-8036E9AF-8FF1-4D5C-B492-1E86B8DC6CC9 Q41637392-7E439595-31A7-43F0-818F-F657664EC163 Q41698570-C0A50C96-8EF4-4C7E-99DF-CD74ED438F64 Q42317503-D39C6F63-8CB7-466A-8BD5-087F05A8C4F0 Q47119773-447446A5-E8B5-421F-A017-23E32767F622 Q47140422-8DB2323E-D69C-4ADB-A01C-1BF4117FE03E Q47942760-FA5E7BF9-8CB2-49FA-A224-7F353C42DBB6 Q48124146-DD891244-8FF2-4871-A1AD-31D4E066A368

P2860

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

http://www.wikidata.org/entity/Q35273654

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@ast

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@en

type

label

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@ast

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@en

prefLabel

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@ast

FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.

@en

P1433

Q35273654-25B439D9-79F4-44C2-827E-475CA290FD70

P1476

Q35273654-FF253D09-B895-409A-B827-88D9C507DDB4

P2093

Q35273654-0E59C5CB-5B20-4BA3-BF1B-6C4F38E4EEB5

Q35273654-4434E508-B048-4E22-8B9C-880FFECCA763

Q35273654-6D05416A-42C9-477A-92FD-DC7AC2FA61EF

Q35273654-736921CA-B039-44CA-8338-E03BB25A3D28

Q35273654-9F68C15A-0015-4801-A8D0-F17BC2C03DD3

Q35273654-B112D2B6-6A28-478B-BB8E-B61C8BCC9117

Q35273654-D92F44A2-914C-45D9-82DF-BE58033222A1

P2860

Q35273654-035EE42E-4F6C-4185-94B2-5170A18FBB8C

Q35273654-0515D64C-09ED-467B-BF93-51B9304B4D37

Q35273654-0587F6D4-626F-4C92-B388-B82AD986DCA1

Q35273654-067AF49C-F84F-4CEF-92E1-EFF33D763848

Q35273654-0E6CAFB2-A4E4-473B-9B3E-2110646399C6

Q35273654-11E9C313-A093-40A4-9DB3-EDD88F9BF7DC

Q35273654-140CC08B-1332-4B59-8D52-3C9C40FFA7F6

Q35273654-1C7A7C6D-0F1A-4B4C-825F-5CF5ADC2935A

Q35273654-20A0406F-E9E7-4E68-9DE7-6C1109ADF8B7

Q35273654-281C57F9-656B-47E6-9334-7FDCB9D49895

P304

Q35273654-8E29BD69-9542-4B12-8578-B2E9C89A744C

P31

Q35273654-6FFCF70C-F474-4F63-81BF-C0A7092F8EE6

P356

Q35273654-2E70BF91-68E0-4213-ACC1-B9BCE47DDD76

P407

Q35273654-E1030ECB-A6A4-407E-8C15-0D2F1740675B

P433

Q35273654-92107DB8-A836-413F-B5D4-06AF03F39642

P478

Q35273654-C5BABAF3-F758-4771-83E5-EF3258BCE82C

P50

Q35273654-96683AF1-7A00-47CB-A0A4-A185D12941D2

P577

Q35273654-97FB3FA3-FABB-46EC-A895-D583246DFB1C

P5875

Q35273654-2E11A580-2105-4573-93E5-4286886789C5

P698

Q35273654-BF5D8C3E-2856-4EC1-BED4-5EBF9D192CFC

P932

Q35273654-38A86E2E-1C04-46FC-B387-582AD222C011

P356

ONCOTARGET.2957

P1433

P1476

FOXM1 confers to epithelial-me ...... helial ovarian carcinoma cells

@en

P2093

Chang-Hwa Chang

http://www.w3.org/2001/XMLSchema#string

Cheng-Yang Chou

http://www.w3.org/2001/XMLSchema#string

Huei-Yu Tsai

http://www.w3.org/2001/XMLSchema#string

Keng-Fu Hsu

http://www.w3.org/2001/XMLSchema#string

Soon-Cen Huang

http://www.w3.org/2001/XMLSchema#string

Wen-Tai Chiu

http://www.w3.org/2001/XMLSchema#string

Yu-Fang Huang

http://www.w3.org/2001/XMLSchema#string

P2860

FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis

The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells

Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes

The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis

Induction of human epithelial stem/progenitor expansion by FOXM1

FOXM1 confers acquired cisplatin resistance in breast cancer cells

Integrated genomic analyses of ovarian carcinoma

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

P304

2349-2365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2957

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Chien-Chin Chen

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270004311

http://www.w3.org/2001/XMLSchema#string

P698

25537512

http://www.w3.org/2001/XMLSchema#string

P932

4385856

http://www.w3.org/2001/XMLSchema#string